Pharmaceutical News and Articles

FDA Warns of Accidental Overdoses from Compounded Versions of Ozempic

include severe nausea, vomiting and hypoglycemia, the FDA said. Other side effects include fainting, headache, migraine, dehydration, pancreatitis and gallstone

Black Americans 20 Times More Prone to Gun Injuries Than Whites

Black Americans, especially young Black men, face 20 times the odds of gun injury compared to whites, new data shows. Black persons made up only 12.6 of the U.S

Ozempic's Latest Role: Helping Smokers Quit

a marker for folks who felt they needed help to quit smoking.The researchers found that patients taking semaglutide were 32 less likely to seek out such therapi

USDA Toughens Rules on Salmonella in Poultry

three strains in chicken and three in turkeys, the Associated Press reported.If testing finds poultry with any of those salmonella strains or at levels above th

FDA Approves Zunveyl (benzgalantamine) for the Treatment of Alzheimer's Disease

Early School-Based Health Promotion Intervention Beneficial

Elementary school interventions may be more effective for abdominal adiposity when started early, according to a study published in the Aug. 6 issue of the Jour

Study Estimates Burden of Firearm Injuries for 2019 to 2020

During 2019 to 2020, there were 252,376 total firearm injuries in the United States, resulting in 84,908 deaths, according to a study published online July 30 i

Semaglutide Seems Beneficial for Comorbid T2DM, Tobacco Use Disorder

For patients with type 2 diabetes mellitus (T2DM) and tobacco use disorder (TUD), new use of semaglutide is associated with lower risk of TUD-related health car

ECT-Induced Seizure Length Tied to Major Depressive Disorder Remission

For patients with major depressive disorder (MDD), seizure duration of 60 to 69 seconds induced by electroconvulsive therapy (ECT) is associated with the highes

Blinatumomab + Chemo Ups Survival in B-Cell Precursor Acute Lymphoblastic Leukemia

For adult patients with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) who have measurable residual disease (MRD)-negative remission, blinatumomab in a